NCT06858839: Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight
- State
- Under way
- Phase
- Phase 3
- People
- 3,853 taking part
- Started
- 12 Mar 2025
- Primary completion
- 21 Jan 2027
- Arms
- Maridebart Cafraglutide High Dose, Maridebart Cafraglutide Medium Dose, Maridebart Cafraglutide Low Dose
- Results
- None posted
- 5 Mar 2025: Trial registered
- 12 Mar 2025: Trial started